(15313195), A. T. F., (15313198), H. T. K., (15313201), R. J. S., (15313204), M. J. L., (15313207), S. L., (15117505), A. S. K., . . . (15313249), Y. C. (2025). Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia.
Citação do estilo Chicago (17ª ed.)(15313195), Amir T. Fathi, et al. Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia. 2025.
Citação MLA (9ª ed.)(15313195), Amir T. Fathi, et al. Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia. 2025.